Kestra Medical Technologies, Ltd. (KMTS) stock
KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
$25.10−1.53 (-5.75%)
Close on Nov 20, 2026Market cap $1.50BP/E –Yield –
Kestra Medical Technologies gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Kestra Medical Technologies's gross profit for the twelve months ending Jul 31, 2026 was $57.51M, up 99.3% year over year. For fiscal 2026 it was $48.86M, up 101.8% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | $48.86M | +101.8% |
| FY2025 | Apr 30, 2025 | $24.21M | +6587.8% |
| FY2024 | Apr 30, 2024 | $362.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $17.50M | +97.7% |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | $15.68M | +105.5% |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | $12.91M | +97.1% |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | $11.42M | +96.0% |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | $8.85M | +110.7% |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | $7.63M | – |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | $6.55M | – |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | $5.83M | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | $4.20M | – |
See a number that looks wrong?